Getz Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private branded-generic pharmaceutical manufacturer · Karachi · Pakistan
International branded-generic pharmaceutical manufacturer headquartered in Karachi with operations across multiple therapeutic areas and countries.
Getz Pharma products in Pakistan
Getz Pharma (Pvt) Limited has 282 medicine presentations registered in Pakistan under 79 brands, covering 63 generic medicines. Most of its products are in Anti-infectives, Endocrine & metabolic and CNS & mental health. Its brands with the most registered strengths and packs are Risperiget (Risperidone), Risek (Omeprazole), Diampa-M (Empagliflozin + Metformin) and Ribazole (Ribavirin). 282 products have an official DRAP price on MedInfoBase. See all 79 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Getz Pharma (Pvt.) Limited
- Company type
- Private branded-generic pharmaceutical manufacturer
- Address
- 29-30/27, Korangi Industrial Area, Karachi, Sindh, Pakistan
- Website
- getzpharma.com ↗
- Phone
- +92 21 111 111 511
- Official contact
- Contact page ↗
- Official company profile ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Getz Pharma (Pvt) Limited is priced against the market
250 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Voriget | Voriconazole | 50 mg | Tablet | 10's | 125303 | PKR 642.29 | PKR 64.23/tablet | 🔒 Pharma Pro |
| Voriget | Voriconazole | 200 mg | Tablet | 10's | 125304 | PKR 1,766.30 | PKR 176.63/tablet | 🔒 Pharma Pro |
| Xeftazidime | Ceftazidime | 250 mg | Injection | 1's | 120362 | PKR 159.64 | PKR 159.64/vial/unit | 🔒 Pharma Pro |
| Xeftazidime | Ceftazidime | 500 mg | Injection | 1's | 120363 | PKR 242.83 | PKR 242.83/vial/unit | 🔒 Pharma Pro |
| Xeftazidime | Ceftazidime | 1000 mg | Injection | 1's | 120364 | PKR 456.12 | PKR 456.12/vial/unit | 🔒 Pharma Pro |
| Xelotab | Capecitabine | 500 mg | Tablet | 120's | 110532 | PKR 28,055.35 | PKR 233.79/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 1000 mg | Tablet | 30's | 081078 | PKR 5,258.12 | PKR 175.27/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 1000 mg | Tablet | 10's | 081078 | PKR 1,752.70 | PKR 175.27/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 750 mg | Tablet | 30's | 081079 | PKR 4,206.50 | PKR 140.22/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 750 mg | Tablet | 10's | 081079 | PKR 1,402.17 | PKR 140.22/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 500 mg | Tablet | 30's | 081080 | PKR 3,154.87 | PKR 105.16/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 500 mg | Tablet | 10's | 081080 | PKR 1,051.63 | PKR 105.16/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 250 mg | Tablet | 10's | 090777 | PKR 615.47 | PKR 61.55/tablet | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 100 mg/mL | Oral solution | 60ml | 102862 | PKR 813.78 | PKR 13.56/mL | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 100 mg/mL | Oral solution | 120ml | 102862 | PKR 1,627.56 | PKR 13.56/mL | 🔒 Pharma Pro |
| Xeticam | Levetiracetam | 100 mg/mL | Oral solution | 30ml | 102862 | PKR 429.50 | PKR 14.32/mL | 🔒 Pharma Pro |
| Xeticam IV | Levetiracetam | 500 mg/5 mL | IV injection | 10's | 092964 | PKR 6,390.46 | PKR 639.05/vial/unit | No comparator |
| Xeticam IV | Levetiracetam | 500 mg/5 mL | IV injection | 1's | 092964 | PKR 639.05 | PKR 639.05/vial/unit | No comparator |
| Xeticam XR | Levetiracetam | 500 mg | Extended-release tablet | 10's | 081077 | PKR 1,155.58 | PKR 115.56/tablet | 🔒 Pharma Pro |
| Xeticam XR | Levetiracetam | 1000 mg | Extended-release tablet | 10's | 118330 | PKR 1,869.89 | PKR 186.99/tablet | No comparator |
| Xicard 25mg TabletRegistry verified | Carvedilol | — | — | — | 044272Official source ↗ | No indexed price | — | — |
| Xicard 6.25mg TabletRegistry verified | Carvedilol | — | — | — | 044271Official source ↗ | No indexed price | — | — |
| Xiflox 400mg TabletsRegistry verified | Moxifloxacin as Hydrochloride | — | — | — | 003280-EXOfficial source ↗ | No indexed price | — | — |
| Xiflox I.V Infusion 400mg/250mLRegistry verified | Moxifloxacin | — | — | — | 003281-EXOfficial source ↗ | No indexed price | — | — |
| Ximatof | Cefotaxime | 1 g | Powder for injection | 1's | 118061 | PKR 300.58 | PKR 300.58/vial/unit | 🔒 Pharma Pro |
| Ximatof | Cefotaxime | 500 mg | Powder for injection | 1's | 118062 | PKR 167.12 | PKR 167.12/vial/unit | 🔒 Pharma Pro |
| Ximatof | Cefotaxime | 250 mg | Powder for injection | 1's | 118063 | PKR 110.88 | PKR 110.88/vial/unit | 🔒 Pharma Pro |
| Zetro | Azithromycin | 100 mg/5 mL | Suspension | 30mL | 045374 | PKR 205.29 | PKR 6.84/mL | 🔒 Pharma Pro |
| Zetro | Azithromycin | 250 mg | Capsule | 6's | 045375 | PKR 320.36 | PKR 53.39/capsule | 🔒 Pharma Pro |
| Zetro | Azithromycin | 250 mg | Capsule | 10's | 045375 | PKR 533.95 | PKR 53.40/capsule | 🔒 Pharma Pro |
| ZetroSource observed | Azithromycin | 200 mg/5 mL | Held for normalizationSource reported: Capsule · structural field conflict | 15ml | 047145Official source ↗ | No indexed price | — | — |
| ZetroSource observed | Azithromycin | 200 mg/5 mL | Held for normalizationSource reported: Capsule · structural field conflict | 25ml | 047145Official source ↗ | No indexed price | — | — |
| Zetro | Azithromycin | 500 mg | Tablet | 6's | 053120 | PKR 575.83 | PKR 95.97/tablet | 🔒 Pharma Pro |
| Zetro | Azithromycin | 500 mg | Tablet | 1x3's | 053120 | PKR 286.86 | PKR 95.62/tablet | 🔒 Pharma Pro |
| Zetro | Azithromycin | 250 mg | Tablet | 6's | 066913 | PKR 225.10 | PKR 37.52/tablet | 🔒 Pharma Pro |
| Zetro SuspesnionSource observed | Azithromycin | 200 mg/5 mL | Held for normalizationSource reported: Capsule · structural field conflict | 30ml | 047145Official source ↗ | No indexed price | — | — |
| Zetro Suspesnion 200mg/5ml Each 5mL contains:Azithromycin.…200mg(as dihydrate)Source observed | — | — | — | 15ml | 047145Official source ↗ | No indexed price | — | — |
| Zoldap | Linezolid | 200 mg/100 mL | IV infusion | 100mL | 055431 | PKR 704.54 | PKR 7.05/mL | 🔒 Pharma Pro |
| Zoldap | Linezolid | 400 mg/200 mL | IV infusion | 200mL | 055432 | PKR 814.49 | PKR 4.07/mL | 🔒 Pharma Pro |
| Zoldap | Linezolid | 600 mg/300 mL | IV infusion | 300mL | 055433 | PKR 1,221.73 | PKR 4.07/mL | 🔒 Pharma Pro |
| Zoldap | Linezolid | 400 mg | Tablet | 12's | 055434 | PKR 2,997.12 | PKR 249.76/tablet | 🔒 Pharma Pro |
| Zoldap | Linezolid | 400 mg | Tablet | 10's | 055434 | PKR 2,362.76 | PKR 236.28/tablet | 🔒 Pharma Pro |
| Zoldap | Linezolid | 600 mg | Tablet | 12's | 055439 | PKR 5,247.02 | PKR 437.25/tablet | 🔒 Pharma Pro |
| Zoldap | Linezolid | 600 mg | Tablet | 10's | 055439 | PKR 4,135.32 | PKR 413.53/tablet | 🔒 Pharma Pro |
| Zoldap | Linezolid | 100 mg/5 mL | Suspension | 60ml | 104291 | PKR 525.24 | PKR 8.75/mL | 🔒 Pharma Pro |
| Zoldap | Linezolid | 100 mg/5 mL | Suspension | 120ml | 104291 | PKR 997.95 | PKR 8.32/mL | 🔒 Pharma Pro |
| Zoliget Tablets 15mg + 2mgRegistry verified | Glimepiride , Pioglitazone | — | — | — | 053326Official source ↗ | No indexed price | — | — |
| Zoliget Tablets 30mg + 2mgRegistry verified | Glimepiride , Pioglitazone | — | — | — | 050713Official source ↗ | No indexed price | — | — |
| Zoliget Tablets 30mg + 4mgRegistry verified | Glimepiride , Pioglitazone | — | — | — | 050714Official source ↗ | No indexed price | — | — |
All 79 Getz Pharma brands in Pakistan
- Acetaget Paracetamol · 1 g/100 mL infusion, 500 mg tablet
- Acuria Atracurium besylate · 25 mg/2.5 mL injection, 30 mg/3 mL injection, 50 mg/5 mL injection
- Amclav Amoxicillin + clavulanic acid · 125 mg + 31.25 mg / 5 mL suspension, 125 mg + 31.25 mg/5 mL suspension, 250 mg + 125 mg tablet
- Amclav Plus Amoxicillin + clavulanic acid · 400 mg + 57 mg/5 mL suspension
- Amtas Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
- Apixaget Apixaban · 2.5 mg tablet, 5 mg tablet
- Artheget Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg + 480 mg tablet
- Artheget DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Artheget EZ Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Artheget Junior Artemether + Lumefantrine · 15 mg/5 mL + 90 mg/5 mL suspension
- Artheget Junior DS Artemether + Lumefantrine · 30 mg/5 mL + 180 mg/5 mL suspension
- Basagine Insulin glargine · 100 IU injection, 100 IU/mL injection, 100 units/mL injection
- Cefiget Cefixime · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
- Ceftazid Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Cipesta Ciprofloxacin · 100 mg/50 mL infusion, 125 mg/5 mL suspension, 200 mg/100 mL infusion
- Cipesta DS Ciprofloxacin · 400 mg/100 mL infusion
- Cipesta XR Ciprofloxacin · 1000 mg tablet, 500 mg tablet
- Claritek Clarithromycin · 125 mg/5 mL drops, 250 mg tablet, 250 MG/5 mL suspension
- Clopiget Clopidogrel · 75 mg tablet
- Co-Tasmi Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- Daclaget Daclatasvir · 30 mg tablet, 60 mg tablet
- Diampa Empagliflozin · 10 mg tablet, 25 mg tablet
- Diampa-M Empagliflozin + Metformin · 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet, 12.5 mg + 850 mg tablet
- Diampa-M XR Empagliflozin + Metformin · 10 mg + 1000 mg tablet, 12.5 mg + 1000 mg tablet, 25 mg + 1000 mg tablet
- Dravix Tranexamic acid · 500 mg capsule, 500 mg/5 mL injection
- Ferotein Chewable Iron protein succinylate + Folic acid · 400 mg + 2.5 mg tablet
- Folic Acid Folic acid · 5 mg tablet
- Formiget Budesonide + Formoterol · 200 mcg + 6 mcg inhalation, 400 mcg + 12 mcg inhalation
- Fortide Budesonide + Formoterol · 200 mcg + 6 mcg per metered dose inhalation
- Getacet Acetazolamide · 250 mg tablet
- Getamlo Amlodipine · 10 mg tablet, 5 mg tablet
- Getofin Ceftriaxone · 1 g injection, 2000 mg injection, 250 mg injection
- Getzid MR Gliclazide · 30 mg tablet, 60 mg tablet
- Getzpenem Meropenem · 1 g injection, 500 mg injection
- HCQ Hydroxychloroquine · 200 mg tablet
- Insuget N Human insulin (isophane/NPH) · 100 IU/mL injection
- Insuget R Regular human insulin · 100 IU/mL injection
- Insulog Insulin lispro · 100 units/mL injection
- Leflox Levofloxacin · 250 mg tablet, 500 mg tablet, 500 mg/100 mL infusion
- Lilac Lactulose · 3.35 g/5 mL syrup
- Lisino-H Lisinopril + Hydrochlorothiazide · 20 mg + 12.5 mg tablet
- Lopinaget Lopinavir + Ritonavir · 100 mg + 25 mg tablet, 200 mg + 50 mg tablet
- Lotass Losartan · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Lotass Plus Losartan + Hydrochlorothiazide · 100 mg + 25 mg tablet, 50 mg + 12.5 mg tablet
- M-low Plus Amlodipine + Hydrochlorothiazide · 10 mg + 12.5 mg tablet, 5 mg + 12.5 mg tablet
- Meroget Meropenem · 1 g injection, 500 mg injection
- Miura-D Cholecalciferol · 5 mg injection, 5 mg/mL (200,000 IU/mL) injection
- Moxiget Moxifloxacin · 400 mg tablet, 400 mg/250 mL infusion
- Nitrobact Nitrofurantoin · 100 mg tablet
- Onseget Ondansetron · 4 mg/2 mL injection, 4 mg/5 mL solution, 8 mg tablet
- Optra HFA Ipratropium bromide · 20 mcg/metered dose inhalation
- Optra Nebuliser Ipratropium bromide · 0.25 mg inhalation, 0.25 mg/mL inhalation, 500 mcg/2 mL solution
- Oselavir Oseltamivir · 12 mg/mL suspension, 75 mg capsule
- Ribazole Ribavirin · 400 mg capsule, 500 mg tablet, 600 mg tablet
- Risek Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Risek Insta Omeprazole + Sodium bicarbonate · 20 mg + 1680 mg sachet, 40 mg + 1680 mg sachet
- Risperiget Risperidone · 1 mg tablet, 1 mg/mL solution, 2 mg tablet
- Rivaxo Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
- Salbo HFA Salbutamol · 100 mcg/metered dose inhalation
- Salbuta HFA Salbutamol · 100 mcg/metered dose inhalation
- Sofiget Sofosbuvir · 400 mg tablet
- Sovalget Sodium valproate · 500 mg/5 mL injection
- Sterile water Water for Injection · 10 mL injection
- Syneget-LS Ledipasvir + Sofosbuvir · 90 mg + 400 mg tablet
- Tenofo-B Tenofovir disoproxil · 300 mg tablet
- Tioget Tiotropium · 18 mcg capsule
- Tioget Inhalation Tiotropium · 18 mcg capsule
- Trastuget Trastuzumab · 150 mg injection, 440 mg infusion
- Unipeg Peginterferon alfa-2a · 180 mcg injection, 180 mcg/mL injection
- Velpaget Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- Voriget Voriconazole · 200 mg tablet, 50 mg tablet
- Xeftazidime Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
- Xelotab Capecitabine · 500 mg tablet
- Xeticam Levetiracetam · 100 mg/mL solution, 1000 mg tablet, 250 mg tablet
- Xeticam IV Levetiracetam · 500 mg/5 mL injection
- Xeticam XR Levetiracetam · 1000 mg tablet, 500 mg tablet
- Ximatof Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Zetro Azithromycin · 100 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
- Zoldap Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 400 mg tablet
Getz Pharma: common questions
How many products does Getz Pharma have in Pakistan?
Getz Pharma (Pvt) Limited has 282 registered medicine presentations in Pakistan, sold under 79 brands and covering 63 generic medicines.
What are the main brands of Getz Pharma?
By number of registered strengths and packs, its largest brands are Risperiget (Risperidone), Risek (Omeprazole), Diampa-M (Empagliflozin + Metformin), Ribazole (Ribavirin) and Xeticam (Levetiracetam). This is not a sales ranking.
Which therapy areas does Getz Pharma cover?
The most products are in Anti-infectives (125), Endocrine & metabolic (37), CNS & mental health (30), Gastrointestinal & hepatology (27) and Cardiovascular (23).
Where can I see Getz Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.